These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 11089838)

  • 21. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy.
    Ingelman-Sundberg M
    J Intern Med; 2001 Sep; 250(3):186-200. PubMed ID: 11555122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
    Evans WE; Johnson JA
    Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
    Johnson AD; Wang D; Sadee W
    Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
    Pilotto A; Panza F; Seripa D
    Curr Drug Metab; 2011 Sep; 12(7):621-34. PubMed ID: 21495974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical relevance of drug metabolism polymorphisms].
    Mikus G
    Ther Umsch; 2000 Sep; 57(9):573-8. PubMed ID: 11036438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics and anesthesiologists.
    Galley HF; Mahdy A; Lowes DA
    Pharmacogenomics; 2005 Dec; 6(8):849-56. PubMed ID: 16296947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tailor-made drug therapy].
    Ozawa S; Sawada J
    Nihon Rinsho; 2001 Jan; 59(1):195-201. PubMed ID: 11197856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping].
    Johansen PW; Bergan S; Rootwelt H; Kvittingen EA; Rugstad HE
    Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2781-3. PubMed ID: 12523145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically determined adverse drug reactions involving metabolism.
    Lennard MS
    Drug Saf; 1993 Jul; 9(1):60-77. PubMed ID: 8347292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
    Becquemont L
    Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
    Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacogenomics and the path towards personalized medicine].
    Belloso WH; Redal MA
    Medicina (B Aires); 2010; 70(3):265-74. PubMed ID: 20529779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interindividual differences in the reaction to drugs and poisons].
    Meyer UA
    Ther Umsch; 1992 Feb; 49(2):97-101. PubMed ID: 1553631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacogenetics. Tailored therapy in medicine -- opportunities and challenges].
    Scharplatz M; Puhan M; Steurer J; Bachmann LM
    Praxis (Bern 1994); 2004 Mar; 93(10):359-65. PubMed ID: 15052854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional regulation and pharmacogenomics.
    Georgitsi M; Zukic B; Pavlovic S; Patrinos GP
    Pharmacogenomics; 2011 May; 12(5):655-73. PubMed ID: 21619428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.